Industry Research Reports

Home > Reports > Pharma & Healthcare > Anthracycline Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Anthracycline Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-04

Pages: 123 Pages

Report ld: 2432608

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Anthracycline Anticancer Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Anthracycline Anticancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anthracycline Anticancer Drugs by region & country, by Type, and by Application.

The Anthracycline Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthracycline Anticancer Drugs.

Market Segmentation

Report Metric
Details
Report Title
Anthracycline Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Anthracycline Anticancer Drugs Companies Covered
Pfizer, Ebewe Pharma, Sicor Societa, Hanhui Pharmaceuticals, Hisun Pharmaceutical, New Time Pharmaceutical, Main Luck Pharmaceuticals, Jinyuan Pharmaceutical, Pude Pharmaceutical, Lingnan Pharmaceutical, CSPC OUYI Pharmaceutical, Beijing Union Pharmaceutical
Global Anthracycline Anticancer Drugs Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anthracycline Anticancer Drugs Market, Segment by Type
Daunorubicin

Adriamycin

Epirubicin

Pirarubicin

Aclarithromycin

Others
Global Anthracycline Anticancer Drugs Market, Segment by Application
Acute Leukemia

Lymphoma

Breast Cancer

Stomach Cancer

Soft Tissue Sarcoma

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anthracycline Anticancer Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anthracycline Anticancer Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anthracycline Anticancer Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Anthracycline Anticancer Drugs Product Introduction
    1.2 Global Anthracycline Anticancer Drugs Market Size Forecast
        1.2.1 Global Anthracycline Anticancer Drugs Sales Value (2019-2030)
        1.2.2 Global Anthracycline Anticancer Drugs Sales Volume (2019-2030)
        1.2.3 Global Anthracycline Anticancer Drugs Sales Price (2019-2030)
    1.3 Anthracycline Anticancer Drugs Market Trends & Drivers
        1.3.1 Anthracycline Anticancer Drugs Industry Trends
        1.3.2 Anthracycline Anticancer Drugs Market Drivers & Opportunity
        1.3.3 Anthracycline Anticancer Drugs Market Challenges
        1.3.4 Anthracycline Anticancer Drugs Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Anthracycline Anticancer Drugs Players Revenue Ranking (2023)
    2.2 Global Anthracycline Anticancer Drugs Revenue by Company (2019-2024)
    2.3 Global Anthracycline Anticancer Drugs Players Sales Volume Ranking (2023)
    2.4 Global Anthracycline Anticancer Drugs Sales Volume by Company Players (2019-2024)
    2.5 Global Anthracycline Anticancer Drugs Average Price by Company (2019-2024)
    2.6 Key Manufacturers Anthracycline Anticancer Drugs Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Anthracycline Anticancer Drugs Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Anthracycline Anticancer Drugs
    2.9 Anthracycline Anticancer Drugs Market Competitive Analysis
        2.9.1 Anthracycline Anticancer Drugs Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Anthracycline Anticancer Drugs Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthracycline Anticancer Drugs as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Daunorubicin
        3.1.2 Adriamycin
        3.1.3 Epirubicin
        3.1.4 Pirarubicin
        3.1.5 Aclarithromycin
        3.1.6 Others
    3.2 Global Anthracycline Anticancer Drugs Sales Value by Type
        3.2.1 Global Anthracycline Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Anthracycline Anticancer Drugs Sales Value, by Type (2019-2030)
        3.2.3 Global Anthracycline Anticancer Drugs Sales Value, by Type (%) (2019-2030)
    3.3 Global Anthracycline Anticancer Drugs Sales Volume by Type
        3.3.1 Global Anthracycline Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Anthracycline Anticancer Drugs Sales Volume, by Type (2019-2030)
        3.3.3 Global Anthracycline Anticancer Drugs Sales Volume, by Type (%) (2019-2030)
    3.4 Global Anthracycline Anticancer Drugs Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Acute Leukemia
        4.1.2 Lymphoma
        4.1.3 Breast Cancer
        4.1.4 Stomach Cancer
        4.1.5 Soft Tissue Sarcoma
        4.1.6 Others
    4.2 Global Anthracycline Anticancer Drugs Sales Value by Application
        4.2.1 Global Anthracycline Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Anthracycline Anticancer Drugs Sales Value, by Application (2019-2030)
        4.2.3 Global Anthracycline Anticancer Drugs Sales Value, by Application (%) (2019-2030)
    4.3 Global Anthracycline Anticancer Drugs Sales Volume by Application
        4.3.1 Global Anthracycline Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Anthracycline Anticancer Drugs Sales Volume, by Application (2019-2030)
        4.3.3 Global Anthracycline Anticancer Drugs Sales Volume, by Application (%) (2019-2030)
    4.4 Global Anthracycline Anticancer Drugs Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Anthracycline Anticancer Drugs Sales Value by Region
        5.1.1 Global Anthracycline Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Anthracycline Anticancer Drugs Sales Value by Region (2019-2024)
        5.1.3 Global Anthracycline Anticancer Drugs Sales Value by Region (2025-2030)
        5.1.4 Global Anthracycline Anticancer Drugs Sales Value by Region (%), (2019-2030)
    5.2 Global Anthracycline Anticancer Drugs Sales Volume by Region
        5.2.1 Global Anthracycline Anticancer Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Anthracycline Anticancer Drugs Sales Volume by Region (2019-2024)
        5.2.3 Global Anthracycline Anticancer Drugs Sales Volume by Region (2025-2030)
        5.2.4 Global Anthracycline Anticancer Drugs Sales Volume by Region (%), (2019-2030)
    5.3 Global Anthracycline Anticancer Drugs Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Anthracycline Anticancer Drugs Sales Value, 2019-2030
        5.4.2 North America Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Anthracycline Anticancer Drugs Sales Value, 2019-2030
        5.5.2 Europe Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Anthracycline Anticancer Drugs Sales Value, 2019-2030
        5.6.2 Asia Pacific Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Anthracycline Anticancer Drugs Sales Value, 2019-2030
        5.7.2 South America Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Anthracycline Anticancer Drugs Sales Value, 2019-2030
        5.8.2 Middle East & Africa Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Anthracycline Anticancer Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Anthracycline Anticancer Drugs Sales Value
        6.2.1 Key Countries/Regions Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Anthracycline Anticancer Drugs Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.3.2 United States Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.4.2 Europe Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.5.2 China Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.6.2 Japan Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.7.2 South Korea Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.8.2 Southeast Asia Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Anthracycline Anticancer Drugs Sales Value, 2019-2030
        6.9.2 India Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Anthracycline Anticancer Drugs Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Information
        7.1.2 Pfizer Introduction and Business Overview
        7.1.3 Pfizer Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Pfizer Anthracycline Anticancer Drugs Product Offerings
        7.1.5 Pfizer Recent Development
    7.2 Ebewe Pharma
        7.2.1 Ebewe Pharma Company Information
        7.2.2 Ebewe Pharma Introduction and Business Overview
        7.2.3 Ebewe Pharma Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Ebewe Pharma Anthracycline Anticancer Drugs Product Offerings
        7.2.5 Ebewe Pharma Recent Development
    7.3 Sicor Societa
        7.3.1 Sicor Societa Company Information
        7.3.2 Sicor Societa Introduction and Business Overview
        7.3.3 Sicor Societa Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Sicor Societa Anthracycline Anticancer Drugs Product Offerings
        7.3.5 Sicor Societa Recent Development
    7.4 Hanhui Pharmaceuticals
        7.4.1 Hanhui Pharmaceuticals Company Information
        7.4.2 Hanhui Pharmaceuticals Introduction and Business Overview
        7.4.3 Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Product Offerings
        7.4.5 Hanhui Pharmaceuticals Recent Development
    7.5 Hisun Pharmaceutical
        7.5.1 Hisun Pharmaceutical Company Information
        7.5.2 Hisun Pharmaceutical Introduction and Business Overview
        7.5.3 Hisun Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Hisun Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.5.5 Hisun Pharmaceutical Recent Development
    7.6 New Time Pharmaceutical
        7.6.1 New Time Pharmaceutical Company Information
        7.6.2 New Time Pharmaceutical Introduction and Business Overview
        7.6.3 New Time Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 New Time Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.6.5 New Time Pharmaceutical Recent Development
    7.7 Main Luck Pharmaceuticals
        7.7.1 Main Luck Pharmaceuticals Company Information
        7.7.2 Main Luck Pharmaceuticals Introduction and Business Overview
        7.7.3 Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Product Offerings
        7.7.5 Main Luck Pharmaceuticals Recent Development
    7.8 Jinyuan Pharmaceutical
        7.8.1 Jinyuan Pharmaceutical Company Information
        7.8.2 Jinyuan Pharmaceutical Introduction and Business Overview
        7.8.3 Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.8.5 Jinyuan Pharmaceutical Recent Development
    7.9 Pude Pharmaceutical
        7.9.1 Pude Pharmaceutical Company Information
        7.9.2 Pude Pharmaceutical Introduction and Business Overview
        7.9.3 Pude Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Pude Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.9.5 Pude Pharmaceutical Recent Development
    7.10 Lingnan Pharmaceutical
        7.10.1 Lingnan Pharmaceutical Company Information
        7.10.2 Lingnan Pharmaceutical Introduction and Business Overview
        7.10.3 Lingnan Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Lingnan Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.10.5 Lingnan Pharmaceutical Recent Development
    7.11 CSPC OUYI Pharmaceutical
        7.11.1 CSPC OUYI Pharmaceutical Company Information
        7.11.2 CSPC OUYI Pharmaceutical Introduction and Business Overview
        7.11.3 CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.11.5 CSPC OUYI Pharmaceutical Recent Development
    7.12 Beijing Union Pharmaceutical
        7.12.1 Beijing Union Pharmaceutical Company Information
        7.12.2 Beijing Union Pharmaceutical Introduction and Business Overview
        7.12.3 Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
        7.12.5 Beijing Union Pharmaceutical Recent Development

 8 Industry Chain Analysis
    8.1 Anthracycline Anticancer Drugs Industrial Chain
    8.2 Anthracycline Anticancer Drugs Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Anthracycline Anticancer Drugs Sales Model
        8.5.2 Sales Channel
        8.5.3 Anthracycline Anticancer Drugs Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Anthracycline Anticancer Drugs Market Trends
    Table 2. Anthracycline Anticancer Drugs Market Drivers & Opportunity
    Table 3. Anthracycline Anticancer Drugs Market Challenges
    Table 4. Anthracycline Anticancer Drugs Market Restraints
    Table 5. Global Anthracycline Anticancer Drugs Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Anthracycline Anticancer Drugs Revenue Market Share by Company (2019-2024)
    Table 7. Global Anthracycline Anticancer Drugs Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Anthracycline Anticancer Drugs Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Anthracycline Anticancer Drugs Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Anthracycline Anticancer Drugs Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Anthracycline Anticancer Drugs Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Anthracycline Anticancer Drugs
    Table 13. Global Anthracycline Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthracycline Anticancer Drugs as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anthracycline Anticancer Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Anthracycline Anticancer Drugs Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Anthracycline Anticancer Drugs Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Anthracycline Anticancer Drugs Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Anthracycline Anticancer Drugs Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Anthracycline Anticancer Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Anthracycline Anticancer Drugs Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Anthracycline Anticancer Drugs Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Anthracycline Anticancer Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Anthracycline Anticancer Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Anthracycline Anticancer Drugs Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Anthracycline Anticancer Drugs Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Anthracycline Anticancer Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Anthracycline Anticancer Drugs Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Anthracycline Anticancer Drugs Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Anthracycline Anticancer Drugs Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Anthracycline Anticancer Drugs Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Anthracycline Anticancer Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Anthracycline Anticancer Drugs Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Anthracycline Anticancer Drugs Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Anthracycline Anticancer Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Anthracycline Anticancer Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Anthracycline Anticancer Drugs Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Anthracycline Anticancer Drugs Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Anthracycline Anticancer Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Anthracycline Anticancer Drugs Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Anthracycline Anticancer Drugs Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Anthracycline Anticancer Drugs Sales Value by Region (2019-2024) & (%)
    Table 44. Global Anthracycline Anticancer Drugs Sales Value by Region (2025-2030) & (%)
    Table 45. Global Anthracycline Anticancer Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Anthracycline Anticancer Drugs Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Anthracycline Anticancer Drugs Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Anthracycline Anticancer Drugs Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Anthracycline Anticancer Drugs Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Anthracycline Anticancer Drugs Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Anthracycline Anticancer Drugs Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Anthracycline Anticancer Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Anthracycline Anticancer Drugs Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Anthracycline Anticancer Drugs Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Anthracycline Anticancer Drugs Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Anthracycline Anticancer Drugs Sales Volume, (2025-2030) & (K Units)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Pfizer Anthracycline Anticancer Drugs Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. Ebewe Pharma Company Information
    Table 63. Ebewe Pharma Introduction and Business Overview
    Table 64. Ebewe Pharma Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Ebewe Pharma Anthracycline Anticancer Drugs Product Offerings
    Table 66. Ebewe Pharma Recent Development
    Table 67. Sicor Societa Company Information
    Table 68. Sicor Societa Introduction and Business Overview
    Table 69. Sicor Societa Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Sicor Societa Anthracycline Anticancer Drugs Product Offerings
    Table 71. Sicor Societa Recent Development
    Table 72. Hanhui Pharmaceuticals Company Information
    Table 73. Hanhui Pharmaceuticals Introduction and Business Overview
    Table 74. Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Hanhui Pharmaceuticals Anthracycline Anticancer Drugs Product Offerings
    Table 76. Hanhui Pharmaceuticals Recent Development
    Table 77. Hisun Pharmaceutical Company Information
    Table 78. Hisun Pharmaceutical Introduction and Business Overview
    Table 79. Hisun Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Hisun Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 81. Hisun Pharmaceutical Recent Development
    Table 82. New Time Pharmaceutical Company Information
    Table 83. New Time Pharmaceutical Introduction and Business Overview
    Table 84. New Time Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. New Time Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 86. New Time Pharmaceutical Recent Development
    Table 87. Main Luck Pharmaceuticals Company Information
    Table 88. Main Luck Pharmaceuticals Introduction and Business Overview
    Table 89. Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Main Luck Pharmaceuticals Anthracycline Anticancer Drugs Product Offerings
    Table 91. Main Luck Pharmaceuticals Recent Development
    Table 92. Jinyuan Pharmaceutical Company Information
    Table 93. Jinyuan Pharmaceutical Introduction and Business Overview
    Table 94. Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Jinyuan Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 96. Jinyuan Pharmaceutical Recent Development
    Table 97. Pude Pharmaceutical Company Information
    Table 98. Pude Pharmaceutical Introduction and Business Overview
    Table 99. Pude Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Pude Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 101. Pude Pharmaceutical Recent Development
    Table 102. Lingnan Pharmaceutical Company Information
    Table 103. Lingnan Pharmaceutical Introduction and Business Overview
    Table 104. Lingnan Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Lingnan Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 106. Lingnan Pharmaceutical Recent Development
    Table 107. CSPC OUYI Pharmaceutical Company Information
    Table 108. CSPC OUYI Pharmaceutical Introduction and Business Overview
    Table 109. CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. CSPC OUYI Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 111. CSPC OUYI Pharmaceutical Recent Development
    Table 112. Beijing Union Pharmaceutical Company Information
    Table 113. Beijing Union Pharmaceutical Introduction and Business Overview
    Table 114. Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Beijing Union Pharmaceutical Anthracycline Anticancer Drugs Product Offerings
    Table 116. Beijing Union Pharmaceutical Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Anthracycline Anticancer Drugs Downstream Customers
    Table 120. Anthracycline Anticancer Drugs Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anthracycline Anticancer Drugs Product Picture
    Figure 2. Global Anthracycline Anticancer Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anthracycline Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Anthracycline Anticancer Drugs Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Anthracycline Anticancer Drugs Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Anthracycline Anticancer Drugs Report Years Considered
    Figure 7. Global Anthracycline Anticancer Drugs Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Anthracycline Anticancer Drugs Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anthracycline Anticancer Drugs Revenue in 2023
    Figure 10. Anthracycline Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Daunorubicin Picture
    Figure 12. Adriamycin Picture
    Figure 13. Epirubicin Picture
    Figure 14. Pirarubicin Picture
    Figure 15. Aclarithromycin Picture
    Figure 16. Others Picture
    Figure 17. Global Anthracycline Anticancer Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Anthracycline Anticancer Drugs Sales Value Market Share by Type, 2023 & 2030
    Figure 19. Global Anthracycline Anticancer Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 20. Global Anthracycline Anticancer Drugs Sales Volume Market Share by Type, 2023 & 2030
    Figure 21. Global Anthracycline Anticancer Drugs Price by Type (2019-2030) & (US$/Unit)
    Figure 22. Product Picture of Acute Leukemia
    Figure 23. Product Picture of Lymphoma
    Figure 24. Product Picture of Breast Cancer
    Figure 25. Product Picture of Stomach Cancer
    Figure 26. Product Picture of Soft Tissue Sarcoma
    Figure 27. Product Picture of Others
    Figure 28. Global Anthracycline Anticancer Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 29. Global Anthracycline Anticancer Drugs Sales Value Market Share by Application, 2023 & 2030
    Figure 30. Global Anthracycline Anticancer Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 31. Global Anthracycline Anticancer Drugs Sales Volume Market Share by Application, 2023 & 2030
    Figure 32. Global Anthracycline Anticancer Drugs Price by Application (2019-2030) & (US$/Unit)
    Figure 33. North America Anthracycline Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 34. North America Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 35. Europe Anthracycline Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 36. Europe Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 37. Asia Pacific Anthracycline Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 38. Asia Pacific Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 39. South America Anthracycline Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 40. South America Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 41. Middle East & Africa Anthracycline Anticancer Drugs Sales Value (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Anthracycline Anticancer Drugs Sales Value by Country (%), 2023 VS 2030
    Figure 43. Key Countries/Regions Anthracycline Anticancer Drugs Sales Value (%), (2019-2030)
    Figure 44. Key Countries/Regions Anthracycline Anticancer Drugs Sales Volume (%), (2019-2030)
    Figure 45. United States Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 46. United States Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 47. United States Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 48. Europe Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Europe Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 50. Europe Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 51. China Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 52. China Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 53. China Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 54. Japan Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Japan Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 56. Japan Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 57. South Korea Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 58. South Korea Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 59. South Korea Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 60. Southeast Asia Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 61. Southeast Asia Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 62. Southeast Asia Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 63. India Anthracycline Anticancer Drugs Sales Value, (2019-2030) & (US$ Million)
    Figure 64. India Anthracycline Anticancer Drugs Sales Value by Type (%), 2023 VS 2030
    Figure 65. India Anthracycline Anticancer Drugs Sales Value by Application (%), 2023 VS 2030
    Figure 66. Anthracycline Anticancer Drugs Industrial Chain
    Figure 67. Anthracycline Anticancer Drugs Manufacturing Cost Structure
    Figure 68. Channels of Distribution (Direct Sales, and Distribution)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed

Description

The global market for Anthracycline Anticancer Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Anthracycline Anticancer Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anthracycline Anticancer Drugs by region & country, by Type, and by Application.

The Anthracycline Anticancer Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthracycline Anticancer Drugs.

Market Segmentation